Activiteiten
2012
A comparison of post-authorization adverse events of biopharmaceuticals and small molecules within the same anatomical therapeutic chemical class
23 Aug 2012
, Poster presentation at International Society for Pharmaco-epidemiology (Barcelona, Spain)Differences in post-authorization adverse events of biopharmaceuticals and small molecules: patients or products?
17 Apr 2012
, Poster presentation at the 5th TI Pharma Spring Meeting2010
Determinants of Safety Related Regulatory Actions of Biopharmaceuticals
3 Nov 2010
, Poster presentation at ISoP Conference 2010Drivers of Safety Related Regulatory Actions
4 Oct 2010
, Poster presentation at FIGON Dutch Medicines Day (Lunteren, The Netherlands)The contribution of Periodic Safety Update Reporting on Safety-Related Regulatory Actions
15 Apr 2010
, Poster presentation at the TI Pharma Spring MeetingPresentationa at Braunschweig conference: Drugs, Living things and the problems of Standardization
25 Mar 2010
The Impact of Periodic Safety Update Reporting on Safety-Related Regulatory Actions
7 Jan 2010
, Presentation at WHO winter-meeting 20102006
Acute Effects of Discontinuation of Statin Treatment on the Occurence of a First Acute Myocardial Infarction
2006